The goal of this unit is to serve the purposes of national and international research in virology and vaccine development field with a focus on viral pathogens that are of importance and relevance to the national public health. The unit focuses on vaccine development from the bench in vitro evaluation to animal testing and human clinical trials. Vaccines against MERS-CoV are among the priority of this unit with collaborations from a number of international institutes to further evaluate a number of MERS-CoV vaccines in animals and humans. Different vaccine platforms are under developments in the unit such as DNA vectors, adenoviral vectors and poxviral vectors. These platforms are being utilized to develop vaccines against viral and bacterial pathogens relevant to the national public health. The unit also conducts and supports immunology, serology and genetic research that are related to vaccine development.
Main Focus Projects
Notable Collaborative Projects
Current Postgraduate Projects